Randy D. Gascoyne MD

Dr. Gascoyne is a Hematopathologist at the BC Cancer Agency and the sole Canadian member of the International Lymphoma Study Group (ILSG). He has expertise in lymphoma diagnosis and classification, molecular genetics of lymphoma and pathogenesis. His research interests include molecular alterations that characterize lymphomagenesis, biomarker analyses in non-Hodgkin's lymphomas (NHL) and their use as outcome predictors and gene expression microarray profiling . He is involved in many national and international efforts dedicated to study of NHLs. Although a Canadian.

Dr. Gascoyne has served as the lymphoma pathology co-chair for the Eastern Cooperative Oncology Group (ECOG) in the United States since 1999. He is also the co-chairman of the Lunenburg Lymphoma Biomarker Consortium (LLBC), a large and very active international group studying the application of biomarker analyses to clinical practice in lymphoma. He serves as the expert pathologist on several national lymphoma clinical trials organized by the National Cancer Institute of Canada (NCIC) and has just been added as the chairman of a subcommittee to introduce biomarker studies into the Hematological Diseases Subcommittee of the NCIC clinical trials group.